Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 31.53 | -38.51 |
| PEG Ratio (TTM) | 1.10 | 1.85 |
| P/S Ratio (TTM) | 1.82 | 2.21 |
| P/B Ratio (TTM) | 1.76 | 0.56 |
| P/FCF Ratio (TTM) | -373.68 | 34.04 |
| Price to 5YR AVG Earnings Ratio | N/A | -74.43 |
| Price to 5YR AVG FCF Ratio | N/A | 9.25 |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.99% | 1.78% |
| ROE (TTM) | 6.02% | 3.40% |
| Net Profit Margin (TTM) | 5.67% | 3.74% |
| ROIC 5YR AVG | N/A | -0.53% |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 71.97% | -452.80% | N/A |
| Revenue | 4.50% | -0.83% | N/A |
| Net Income | 73.67% | -462.35% | N/A |
| Cash Flow | 15.21% | -13.64% | N/A |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.59 | 1.04 |
| Quick Ratio (TTM) | 0.46 | 0.73 |
| D/E Ratio (TTM) | 0.64 | 0.94 |
| Interest Coverage (TTM) | 2.23 | 5.01 |
| Piotroski F-Score | 6 | 5 |
| Altman Z-Score | 0.98 | 1.95 |
| LTL to 5YR AVG FCF | N/A | -0.57 |
| Shares Outstanding Growth 5YR AVG | N/A | 11.14% |